ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Fusion of the androgen receptor-regulated (AR-regulated) TMPRSS2 gene with ERG in prostate cancer (PCa) causes androgen-stimulated overexpression of ERG, an ETS transcription factor, but critical downstream effectors of ERG-mediating PCa development remain to be established. Expression of the SOX9 transcription factor correlated with TMPRSS2:ERG fusion in 3 independent PCa cohorts, and ERG-dependent expression of SOX9 was confirmed by RNAi in the fusion-positive VCaP cell line. SOX9 has been shown to mediate ductal morphogenesis in fetal prostate and maintain stem/progenitor cell pools in multiple adult tissues, and has also been linked to PCa and other cancers. SOX9 overexpression resulted in neoplasia in murine prostate and stimulated tumor invasion, similarly to ERG. Moreover, SOX9 depletion in VCaP cells markedly impaired invasion and growth in vitro and in vivo, establishing SOX9 as a critical downstream effector of ERG. Finally, we found that ERG regulated SOX9 indirectly by opening a cryptic AR-regulated enhancer in the SOX9 gene. Together, these results demonstrate that ERG redirects AR to a set of genes including SOX9 that are not normally androgen stimulated, and identify SOX9 as a critical downstream effector of ERG in TMPRSS2:ERG fusion-positive PCa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846 · cited 1×
“gen-regulated high-level expression of a transcriptionally active, N-terminal–truncated ERG protein (amino acids 1–44 being deleted in the most common fusion) (2, 3).”
Integrative Genomic Profiling of Human Prostate Cancer
Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,701
Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F. D., Keutel, J., Hustert, E., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90041-8 · Cited by 1,618
Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene
Foster, J. W., Dominguez-Steglich, M. A., Guioli, S., Kwok, C., Weller, P. A., Stevanović, M., Weissenbach, J., Mansour, S., Young, I. D., Goodfellow, P. N., et al. (1994) · Nature · doi:10.1038/372525a0 · Cited by 1,612
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., Febbo, P. G., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4000 · Cited by 1,082
Self-citationSlug and Sox9 Cooperatively Determine the Mammary Stem Cell State
Guo, W., Keckesova, Z., Donaher, J. L., Shibue, T., Tischler, V., Reinhardt, F., Itzkovitz, S., Noske, A., Zürrer-Härdi, U., Bell, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.008 · Cited by 957
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Wang, Q., Li, W., Zhang, Y., Yuan, X., Xu, K., Yu, J., Chen, Z., Beroukhim, R., Wang, H., Lupien, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.056 · Cited by 902
Self-citationYu, J., Yu, J., Mani, R.-S., Cao, Q., Brenner, C. J., Cao, X., Wang, X., Wu, L., Li, J., Hu, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.018 · Cited by 850
Furuyama, K., Kawaguchi, Y., Akiyama, H., Horiguchi, M., Kodama, S., Kuhara, T., Hosokawa, S., Elbahrawy, A., Soeda, T., Koizumi, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.722 · Cited by 834
Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
Tomlins, S. A., Laxman, B., Varambally, S., Cao, X., Yu, J., Helgeson, B. E., Cao, Q., Prensner, J. R., Rubin, M. A., Shah, R. B., et al. (2008) · Neoplasia · doi:10.1593/neo.07822 · Cited by 690
Wang, Q., Li, W., Liu, X. S., Carroll, J. S., Jänne, O. A., Keeton, E. K., Chinnaiyan, A. M., Pienta, K. J., & Brown, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.041 · Cited by 687
Self-citationRecurrent gene fusions in prostate cancer
Kumar-Sinha, C., Tomlins, S. A., & Chinnaiyan, A. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2402 · Cited by 664
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Carver, B. S., Tran, J., Gopalan, A., Chen, Z., Shaikh, S., Carracedo, A., Alimonti, A., Nardella, C., Varmeh, S., Scardino, P. T., et al. (2009) · Nature Genetics · doi:10.1038/ng.370 · Cited by 659
SOX9 is required for maintenance of the pancreatic progenitor cell pool
Seymour, P. A., Freude, K. K., Tran, M. N., Mayes, E. E., Jensen, J., Kist, R., Scherer, G., & Sander, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609217104 · Cited by 567
Schepers, G. E., Teasdale, R. D., & Koopman, P. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00223-x · Cited by 545
Blache, P., van de Wetering, M., Duluc, I., Domon, C., Berta, P., Freund, J.-N., Clevers, H., & Jay, P. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200311021 · Cited by 506
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
King, J. C., Xu, J., Wongvipat, J., Hieronymus, H., Carver, B. S., Leung, D. H., Taylor, B. S., Sander, C., Cardiff, R. D., Couto, S. S., et al. (2009) · Nature Genetics · doi:10.1038/ng.371 · Cited by 477
Cai, C., He, H. H., Chen, S., Coleman, I., Wang, H., Fang, Z., Chen, S., Nelson, P. S., Liu, X. S., Brown, M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.001 · Cited by 454
Self-citationVidal, V. P. I., Chaboissier, M.-C., Lützkendorf, S., Cotsarelis, G., Mill, P., Hui, C.-C., Ortonne, N., Ortonne, J.-P., & Schedl, A. (2005) · Current Biology · doi:10.1016/j.cub.2005.06.064 · Cited by 427
TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion
Perner, S., Mosquera, J.-M., Demichelis, F., Hofer, M. D., Paris, P. L., Simko, J., Collins, C., Bismar, T. A., Chinnaiyan, A. M., De Marzo, A. M., et al. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213424.38503.aa · Cited by 426
Murakami, S., Kan, M., McKeehan, W. L., & de Crombrugghe, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1113 · Cited by 377
Pettersson, A., Graff, R. E., Bauer, S. R., Pitt, M. J., Lis, R. T., Stack, E. C., Martin, N. E., Kunz, L., Penney, K. L., Ligon, A. H., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0042 · Cited by 319
Self-citationAcevedo, V. D., Gangula, R. D., Freeman, K. W., Li, R., Zhang, Y., Wang, F., Ayala, G. E., Peterson, L. E., Ittmann, M., & Spencer, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.004 · Cited by 308
A causal role for ERG in neoplastic transformation of prostate epithelium
Klezovitch, O., Risk, M., Coleman, I., Lucas, J. M., Null, M., True, L. D., Nelson, P. S., & Vasioukhin, V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711711105 · Cited by 302
Gupta, S., Iljin, K., Sara, H., Mpindi, J. P., Mirtti, T., Vainio, P., Rantala, J., Alanen, K., Nees, M., & Kallioniemi, O. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0244 · Cited by 278
Oncogenicity of the Developmental Transcription Factor Sox9
Matheu, A., Collado, M., Wise, C., Manterola, L., Cekaite, L., Tye, A. J., Canamero, M., Bujanda, L., Schedl, A., Cheah, K. S. E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3660 · Cited by 209
Zong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905931106 · Cited by 203
Lincoln, J., Kist, R., Scherer, G., & Yutzey, K. E. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.02.002 · Cited by 187
Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
Wang, J., Cai, Y., Yu, W., Ren, C., Spencer, D. M., & Ittmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1147 · Cited by 173
Schaeffer, E. M., Marchionni, L., Huang, Z., Simons, B., Blackman, A., Yu, W., Parmigiani, G., & Berman, D. M. (2008) · Oncogene · doi:10.1038/onc.2008.327 · Cited by 172
Understanding the role of SOX9 in acquired diseases: lessons from development
Pritchett, J. P., Athwal, V. S., Roberts, N. A., Hanley, N. A., & Hanley, K. P. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.12.001 · Cited by 159
Cai, C., Wang, H., Xu, Y., Chen, S., & Balk, S. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0395 · Cited by 151
Self-citationSOX9 Is Expressed in Human Fetal Prostate Epithelium and Enhances Prostate Cancer Invasion
Wang, H., Leav, I., Ibaragi, S., Wegner, M., Hu, G.-F., Lu, M. L., Balk, S. P., & Yuan, X. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5915 · Cited by 150
Self-citationVitamin D Receptor Protein Expression in Tumor Tissue and Prostate Cancer Progression
Hendrickson, W. K., Flavin, R., Kasperzyk, J. L., Fiorentino, M., Fang, F., Lis, R. T., Fiore, C., Penney, K. L., Ma, J., Kantoff, P. W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.9880 · Cited by 149
Self-citationAnalysis of SOX9 Expression in Colorectal Cancer
Lü, B., Fang, Y., Xu, J., Wang, L., Xu, F., Xu, E., Huang, Q., & Lai, M. (2008) · American Journal of Clinical Pathology · doi:10.1309/ajcpw1w8gjbqgcni · Cited by 145
Kunderfranco, P., Mello-Grand, M., Cangemi, R., Pellini, S., Mensah, A., Albertini, V., Malek, A., Chiorino, G., Catapano, C. V., & Carbone, G. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010547 · Cited by 143
Wang, H., McKnight, N. C., Zhang, T., Lu, M. L., Balk, S. P., & Yuan, X. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1672 · Cited by 143
Self-citationJiang, S. S., Fang, W., Hou, Y.-H., Huang, S.-F. K., Yen, B. L., Chang, J.-L., Li, S., Liu, H., Liu, Y., Huang, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0138 · Cited by 130
Thomsen, M. K., Ambroisine, L., Wynn, S., Cheah, K. S. E., Foster, C. S., Fisher, G., Berney, D. M., Møller, H., Reuter, V. E., Scardino, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2370 · Cited by 126
Hennighausen, L., Wall, R. J., Tillmann, U., Li, M., & Furth, P. A. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590407 · Cited by 124
Zhang, X., Cowper-Sal·lari, R., Bailey, S. D., Moore, J. H., & Lupien, M. (2012) · Genome Research · doi:10.1101/gr.135665.111 · Cited by 122
An EGFR-ERK-SOX9 Signaling Cascade Links Urothelial Development and Regeneration to Cancer
Ling, S., Chang, X., Schultz, L., Lee, T. K., Chaux, A., Marchionni, L., Netto, G. J., Sidransky, D., & Berman, D. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3072 · Cited by 121
Androgen regulation of gene expression.
(2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)07005-3 · Cited by 117
Sox9 is required for prostate development
Thomsen, M. K., Butler, C. M., Shen, M. M., & Swain, A. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.01.030 · Cited by 100
SOX9 expression is a general marker of basal cell carcinoma and adnexal‐related neoplasms
Vidal, V. P. I., Ortonne, N., & Schedl, A. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00815.x · Cited by 91
Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4
Wang, J., Cai, Y., Shao, L., Siddiqui, J., Palanisamy, N., Li, R., Ren, C., Ayala, G., & Ittmann, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2210 · Cited by 82
Sox9 is required for prostate development and prostate cancer initiation
Huang, Z., Hurley, P. J., Simons, B. W., Marchionni, L., Berman, D. M., Ross, A. E., & Schaeffer, E. M. (2012) · Oncotarget · doi:10.18632/oncotarget.531 · Cited by 68
Expression of SOX9 and SOX10 in Central Neuroepithelial Tumor
Kordes, U., & Hagel, C. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9180-7 · Cited by 55
Cited by
Tan, T. Z., Miow, Q. H., Miki, Y., Noda, T., Mori, S., Huang, R. Y., & Thiery, J. P. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404208 · Cited by 792
“Here, we also showed that patients with Mes breast cancers appear to have better OS and DFS than those with Epi breast cancers, seemingly in opposition to what has been previously reported (Hrstka et al , 2010; Taube et al , 2010; Cai et al , 2013).”
Androgen insensitivity syndrome
Hughes, I. A., Davies, J. D., Bunch, T. I., Pasterski, V., Mastroyannopoulou, K., & MacDougall, J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60071-3 · Cited by 553
Yuan, X., Cai, C., Chen, S., Chen, S., Yu, Z., & Balk, S. P. (2014) · Oncogene · doi:10.1038/onc.2013.235 · Cited by 370
Self-citationThe ETS family of oncogenic transcription factors in solid tumours
Sizemore, G. M., Pitarresi, J. R., Balakrishnan, S., & Ostrowski, M. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.20 · Cited by 367
Wnt signaling in triple-negative breast cancer
Pohl, S.-G., Brook, N., Agostino, M., Arfuso, F., Kumar, A. P., & Dharmarajan, A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.14 · Cited by 296
Metadata
- Authors
- Cai, C., Wang, H., He, H. H., Chen, S., He, L., Ma, F., Mucci, L., Wang, Q., Fiore, C., Sowalsky, A. G., Loda, M., Liu, X. S., Brown, M., Balk, S. P., & Yuan, X.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-02-15
- Volume
- 123
- Issue
- 3
- Pages
- 1109-1122
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2141077390
- Cited by
- 273
- References
- 49
- FWCI
- 19.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.